SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001157523-20-000260
Filing Date
2020-02-25
Accepted
2020-02-25 06:30:34
Documents
2
Period of Report
2020-02-25

Document Format Files

Seq Description Document Type Size
1 AURINIA PHARMACEUTICALS INC. 6-K a52178856.htm 6-K 11780
2 EXHIBIT 99.1 a52178856ex99_1.htm EX-99.1 19181
  Complete submission text file 0001157523-20-000260.txt   31958
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 20647194
SIC: 2834 Pharmaceutical Preparations